What: A recent survey revealed that 25% of women under 50 view health influencers as equally trustworthy as traditional providers, sparking debate about online health advice.
Key line: [Details not provided].
Source: PR Newswire.
The debate over rebranding early-stage cancers like DCIS aims to reduce patient anxiety.
One blood pressure medication outperformed another, potentially lowering postpartum readmission rates.
A state representative in Oregon took the witness stand to describe her personal experience with inadequate menopause care.
A marijuana business trade publication reports that some producers are eyeing cannabis-based treatments for women’s health issues.
A randomized control trial found that postpartum women treated with nifedipine had a dramatically lower readmission rate than those on labetalol.
A study from the University of Washington finds significant racial and socioeconomic disparities in accessing same-day diagnostic services after an abnormal mammogram.
The 19th reports on the legal battles facing Dr. Margaret Carpenter over providing abortion pills, with questions about extradition and state protections.
The Trump IVF Executive Order does not make IVF free but instead asks for policy recommendations to lower costs, marking an initial step.
A new survey reveals nearly one in four women under 50 consider health influencers as reliable as healthcare providers.
Michigan law now allows pharmacists to prescribe birth control amid a shortage of OB/GYNs.
New York introduces a shield law to protect doctors who prescribe abortion medications.
A nonprofit representing thousands of physicians is suing to restore access to public health data.
A University of Michigan study finds that women are 60% more likely than men to develop infections following heart surgery.
RFK, Jr. is sworn in as HHS secretary and takes a dig at previous agency messaging while promising “the truth” so mothers can make informed decisions.
A California study found that over 60% of pregnancy-related hemorrhage deaths were preventable due to delays in response and inadequate management.
A study finds that postmenopausal women are significantly more at risk for long COVID compared to men.
The Cut’s Beauty Editor examines Botox resistance—a rare phenomenon where antibodies may reduce the effectiveness of neuromodulators like Botox.
The New York Times investigates whether testosterone therapy could benefit menopausal women.
A comprehensive Danish study reveals that while the absolute risk is low, hormonal contraceptives slightly increase the risk of ischemic stroke and sometimes heart attack.
An intimate essay describes the overwhelming stress of a high-risk pregnancy designation.